{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T05:26:02Z","timestamp":1778304362916,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","labmed.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.cll.2017.07.008","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T23:31:36Z","timestamp":1507851096000},"page":"869-878","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Mast Cell Disease Assessment by Flow Cytometric Analysis"],"prefix":"10.1016","volume":"37","author":[{"given":"Jacqueline M.","family":"Cortazar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Dorfman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cll.2017.07.008_bib1","doi-asserted-by":"crossref","first-page":"1104.e4","DOI":"10.1016\/j.jaci.2010.08.035","article-title":"Mast cell activation syndrome: proposed diagnostic criteria","volume":"126","author":"Akin","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.cll.2017.07.008_bib2","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1182\/blood-2007-11-078097","article-title":"Mast cells and mastocytosis","volume":"112","author":"Metcalfe","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cll.2017.07.008_bib3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1385\/IR:34:2:97","article-title":"Development, migration, and survival of mast cells","volume":"34","author":"Okayama","year":"2006","journal-title":"Immunol Res"},{"issue":"20","key":"10.1016\/j.cll.2017.07.008_bib4","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.cll.2017.07.008_bib5","volume":"vol. 2","author":"Swerdlow","year":"2008"},{"issue":"2","key":"10.1016\/j.cll.2017.07.008_bib6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.iac.2014.01.008","article-title":"Flow cytometry in mastocytosis: utility as a diagnostic and prognostic tool","volume":"34","author":"S\u00e1nchez-Mu\u00f1oz","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"issue":"6","key":"10.1016\/j.cll.2017.07.008_bib7","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/his.12221","article-title":"CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis","volume":"63","author":"Morgado","year":"2013","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.cll.2017.07.008_bib8","doi-asserted-by":"crossref","first-page":"178.e1","DOI":"10.1016\/j.jaci.2015.05.008","article-title":"Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis","volume":"137","author":"\u00c1lvarez-Twose","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.cll.2017.07.008_bib9","doi-asserted-by":"crossref","first-page":"S327","DOI":"10.1016\/j.jaci.2004.01.683","article-title":"Well-differentiated systemic mastocytosis: a new disease variant with mature mast cell phenotype and lack of codon 816 c-kit mutations","volume":"113","author":"Akin","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.cll.2017.07.008_bib10","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1182\/blood-2006-06-028100","article-title":"Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with \u201cidiopathic\u201d anaphylaxis","volume":"110","author":"Akin","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cll.2017.07.008_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cellsig.2007.10.013","article-title":"Kit- and fc epsilonRI-induced differential phosphorylation of the transmembrane adaptor molecule NTAL\/LAB\/LAT2 allows flexibility in its scaffolding function in mast cells","volume":"20","author":"Iwaki","year":"2008","journal-title":"Cell Signal"},{"issue":"6","key":"10.1016\/j.cll.2017.07.008_bib12","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/leu.2008.49","article-title":"The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal\/reactive and myelodysplastic syndrome precursors","volume":"22","author":"Matarraz","year":"2008","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.cll.2017.07.008_bib13","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1398-9995.2005.00865.x","article-title":"Detection of differentiation- and activation-linked cell surface antigens on cultured mast cell progenitors","volume":"60","author":"Schernthaner","year":"2005","journal-title":"Allergy"},{"issue":"11","key":"10.1016\/j.cll.2017.07.008_bib14","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1111\/j.1365-2222.2004.02105.x","article-title":"Detection of tryptase-, chymase+ cells in human CD34 bone marrow progenitors","volume":"34","author":"Shimizu","year":"2004","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"10.1016\/j.cll.2017.07.008_bib15","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1189\/jlb.0507314","article-title":"Differential expression of leukocyte immunoglobulin-like receptors on cord-blood-derived human mast cell progenitors and mature mast cells","volume":"83","author":"Tedla","year":"2008","journal-title":"J\u00a0Leukoc Biol"},{"issue":"10","key":"10.1016\/j.cll.2017.07.008_bib16","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1398-9995.2004.00606.x","article-title":"Human mast cells express receptors for IL-3, IL-5 and GM-CSF; a partial map of receptors on human mast cells cultured in\u00a0vitro","volume":"59","author":"Dahl","year":"2004","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.cll.2017.07.008_bib17","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1398-9995.2006.01133.x","article-title":"Alteration and acquisition of siglecs during in\u00a0vitro maturation of CD34+ progenitors into human mast cells","volume":"61","author":"Yokoi","year":"2006","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.cll.2017.07.008_bib18","doi-asserted-by":"crossref","first-page":"726.e4","DOI":"10.1016\/j.jaci.2009.10.020","article-title":"Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes","volume":"125","author":"Teodosio","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.cll.2017.07.008_bib19","first-page":"1493","article-title":"Flow cytometric analysis of mast cells from normal and pathological human bone marrow samples: identification and enumeration","volume":"149","author":"Orfao","year":"1996","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.cll.2017.07.008_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cyto.b.10072","article-title":"Immunophenotypic analysis of mast cells in mastocytosis: when and how to do it. proposals of the Spanish network on mastocytosis (REMA)","volume":"58","author":"Escribano","year":"2004","journal-title":"Cytometry B Clin Cytom"},{"issue":"7","key":"10.1016\/j.cll.2017.07.008_bib21","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0145-2126(01)00050-9","article-title":"Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis","volume":"25","author":"Escribano","year":"2001","journal-title":"Leuk Res"},{"issue":"3","key":"10.1016\/j.cll.2017.07.008_bib22","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1309\/AJCP5PJWK4QFHWHM","article-title":"High-sensitivity flow cytometric analysis for the evaluation of systemic mastocytosis including the identification of a new flow cytometric criterion for bone marrow involvement","volume":"138","author":"Pozdnyakova","year":"2012","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"10.1016\/j.cll.2017.07.008_bib23","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.leukres.2003.10.035","article-title":"Bone marrow mast cell immunophenotyping in adults with mast cell disease: a prospective study of 33 patients","volume":"28","author":"Pardanani","year":"2004","journal-title":"Leuk Res"},{"issue":"9","key":"10.1016\/j.cll.2017.07.008_bib24","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.5858\/arpa.2013-0537-OA","article-title":"Flow cytometric immunophenotypic analysis of systemic mastocytosis involving bone marrow","volume":"138","author":"Jabbar","year":"2014","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1016\/j.cll.2017.07.008_bib25","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/modpathol.2011.192","article-title":"Immunophenotyping in systemic mastocytosis diagnosis: \u2018CD25 positive\u2019 alone is more informative than the 'CD25 and\/or CD2' WHO criterion","volume":"25","author":"Morgado","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cll.2017.07.008_bib26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/cyto.b.21336","article-title":"Expression of CD2 and CD25 on mast cell populations can be seen outside the setting of systemic mastocytosis","volume":"90B","author":"Cherian","year":"2016","journal-title":"Cytometry B Clin Cytom"},{"issue":"6","key":"10.1016\/j.cll.2017.07.008_bib27","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.3109\/10428194.2014.970546","article-title":"High-sensitivity flow cytometric analysis of mast cell clustering in systemic mastocytosis: a quantitative and statistical analysis","volume":"56","author":"Pozdnyakova","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"10.1016\/j.cll.2017.07.008_bib28","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1309\/AJCP87EYMCYUSDZV","article-title":"FLOCK cluster analysis of mast cell event clustering by high-sensitivity flow cytometry predicts systemic mastocytosis","volume":"144","author":"Dorfman","year":"2015","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.cll.2017.07.008_bib29","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1309\/AJCPZ3J4GEEYIRRA","article-title":"Mast cells in systemic mastocytosis have distinctly brighter CD45 expression by flow cytometry","volume":"143","author":"Chisholm","year":"2015","journal-title":"Am J Clin Pathol"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271217300707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271217300707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T20:23:04Z","timestamp":1535314984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271217300707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0272271217300707"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2017.07.008","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mast Cell Disease Assessment by Flow Cytometric Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2017.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}